Objective:

To explore the potential bioactive compounds, targets, and pathways of Euphorbia Lathyris L. Seed (ELLS) for the treatment of colorectal cancer (CRC), highlighting its significance in addressing current treatment limitations.

Key Findings:

• Euphorbia Lathyris L. Seed contains multiple bioactive compounds with potential anti-cancer properties, including specific examples.
• Network pharmacology effectively elucidates the multi-target mechanisms of ELLS in CRC treatment, revealing novel pathways.
• Identified targets and pathways may provide insights for developing novel CRC therapies, warranting further exploration.

Interpretation:

The study highlights the potential of ELLS as a complementary treatment for CRC, leveraging its multi-component nature to target various pathways involved in cancer progression, thus enhancing existing treatment modalities.

Limitations:

• The study primarily relies on computational methods, which may not fully capture the complexity of biological interactions, potentially affecting the reliability of predictions.
• Experimental validation of predicted targets and pathways is necessary to confirm findings and assess their clinical relevance.

Conclusion:

Euphorbia Lathyris L. Seed shows promise as a therapeutic agent for colorectal cancer, warranting further investigation into its mechanisms and clinical applications, including the need for clinical trials.